Fig 1: Effects of hyper and hypoglycemia on the expression and distribution of glucose transporters. Following exposure to control or altered glycemic conditions, hCMEC/D3 cells were co-stained for immunofluorescence analysis of GLUT-1 (green) and SGLT-1 (red) expression and distribution at 3 h (A) and 24 h (B). Images were captured at 40× (scale: 100 μm) and merged with DAPI. Results were corroborated by western blot analyses at 3 and 24 h. Expression of GLUT-4 was assessed by western blot analysis at 24 h following altered glycemia (C). Data were expressed as mean ± S.E.M. Representative western blots were shown with β-tubulin as loading control. *** p < 0.001, ** p < 0.01, * p < 0.05 and # p < 0.05, vs. control. N = 3-4 samples/condition and replicated twice.
Fig 2: Immunolocation of Sglt1 in the tongue of mSglt1 +/+ and mSglt1 −/− mice; co-staining with Na/K-ATPase-Ab. a In mSglt1 +/+ mice, the plasma membrane of epithelial cells (arrows) surrounding the taste buds were strongly stained (asterisks). This staining was absent in mSglt1 −/− mice. The immunostaining of tongue muscles (m) was similar in both wild-type and mSglt1 −/− mice but not observed with peptide-blocked antibody (data not shown) indicating non-specificity. b Double immunostaining with mSglt1-Ab (red) and Na/K-ATPase-Ab (green) differentiates between plasma membrane staining of epithelial cells for mSglt1, which was observed in the cells surrounding the lateral and bottom sides of the taste buds (arrows) and plasma membrane staining of basal epithelial cells (arrowheads) and of cells within the taste buds (asterisks) for Na+/K+-ATPase. Staining of the tips of longitudinal sectioned taste buds with mSglt1-Ab suggests the location of mSglt1 in cilia of taste cells (double arrowheads). m skeletal muscles. Bar, 20 μm for all images
Fig 3: Mechanical stretch induced SGLT1/2 expression, upregulated ERK and eNOS activation. (a) Fluorescence images showing cardiomyocytes positive for SGLT1/2, p‐ERK, and p‐eNOS. DAPA (SGLT2 inhibitor) or PD98059 (ERK inhibitor) were added to cells, and stretched at 5%, 25% for 24 h. Scale bar = 50 μm. (b–d) Quantifications of SGLT1/2 and p‐ERK. (e) p‐eNOS fluorescence intensity in the stretched cells. Data represented at least three independent experiments in median (interquartile range). Data were analyzed with the Mann–Whitney U test.
Fig 4: Proposed mechanism for Dapagliflozin on troponin I, endoglin (CD105) and ERK activation in the mechanically injured cardiac cell model. Our model depicts the upregulation of troponin I and endoglin (CD105) after mechanically triggered cardiac injury. (a) Cardiomyocytes were seeded on stretchable PDMS membrane, subjected to cyclic stretch at 5% and 25% elongation. After cyclic stretch, troponin I and CD105 were increased, triggering downstream p‐ERK to enter cell nucleus, potentially altered gene transcription that promoted upregulation of p‐eNOS. The accumulated p‐ERK nuclear translocation and p‐eNOS activation led to an imbalanced regulation of sodium/calcium ions. Finally, the cardiomyocytes were overwhelmed by loss of sodium/calcium ions homeostasis, renting the cells susceptible to CVD‐related risk factor. (b) Dapagliflozin (DAPA), the inhibitor having higher affinity for SGLT2, is able to prevent the characteristics of the mechanically provoked biomarkers for cardiac injury. As a result, SGLT2 and/or SGLT1 is crucial in maintaining the normal function of cardiomyocytes.
Fig 5: FAM and vaccine promoted the expression of ileal transporters. (A) Relative protein expression of the ileal apical sodium-dependent bile acid transporter (ASBT), cationic amino acid transporter (CAT1), sodium–glucose cotransporter 1 (SGLT1), and transcobalamin II (TCN2) among groups. (B) ASBT, CAT1, SGLT1, TCN2, fatty acid-binding protein (FABP), and excitatory amino acid carrier 1 (EAAC1) mRNA relative expression of ileum in each group. (*** p < 0.001, ** p < 0.01, * p < 0.05).
Supplier Page from Abcam for Anti-SGLT1 antibody